Effects of typical (haloperidol) and atypical (risperidone) antipsychotic agents on protein expression in rat neural stem cells

Neurochemistry International

Volumn 55, Issue 7, 2009, Pages 558-565

  Kashem, Mohammed A ^a   Ummehany, Rahnuma ^a   Ukai, Wataru ^b   Hashimoto, Eri ^b   Saito, Toshikazu ^b   Mcgregor, Iain S ^a   Matsumoto, Izuru ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Antipsychotic agents; Haloperidol; Neural stem cells; Protein expression; Proteomics; Risperidone

Indexed keywords

ALDEHYDE REDUCTASE; ALPHA ACTIN; ANNEXIN; CREATINE KINASE; CYTOCHROME C OXIDASE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTATHIONE SYNTHASE; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; GUANINE NUCLEOTIDE BINDING PROTEIN BETA SUBUNIT; HALOPERIDOL; HEAT SHOCK PROTEIN 72; HEAT SHOCK PROTEIN 73; LEUCINE ENKEPHALIN; MICROTUBULE ASSOCIATED PROTEIN; OSTEONECTIN; PARVALBUMIN; PERIPHERIN; PHOSPHOLIPASE A2; PROTEIN KINASE B; RISPERIDONE; TROPOMYOSIN; TRYPTOPHAN HYDROXYLASE 2;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; IMAGE ANALYSIS; MOLECULAR MECHANICS; NERVE CELL DIFFERENTIATION; NERVE CELL GROWTH; NEURAL STEM CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ANIMALS; ANTIPSYCHOTIC AGENTS; BLOTTING, WESTERN; CELLS, CULTURED; CYTOSKELETON; DATABASES, FACTUAL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FLUORESCENT ANTIBODY TECHNIQUE; HALOPERIDOL; IMAGE PROCESSING, COMPUTER-ASSISTED; MASS SPECTROMETRY; NERVE TISSUE PROTEINS; NEURONS; OXIDATIVE STRESS; RATS; RISPERIDONE; STEM CELLS;

RATTUS;

EID: 69349096791     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2009.05.007     Document Type: Article

References (83)

1. Aravagiri M., Yuwiler A., and Marder S.R. Distribution after repeated oral administration of different dose levels of risperidone and 9-hydroxyrisperidone in the brain and other tissues of rat. Psychopharmacology 139 (1998) 356-363
2. Arnhold S., Andressen C., Angelov D.N., Vajna R., Volsen S.G., Hescheler J., and Addicks K. Embryonic stem-cell derived neurones express a maturation dependent pattern of voltage-gated calcium channels and calcium-binding proteins. Int. J. Dev. Neurosci. 18 (2000) 201-212
3. Bading H., Ginty D.D., and Greenberg M.E. Regulation of gene expression in hippocampal neurons by distinct calcium signaling pathways. Science 260 (1993) 181-186
4. Blumer J.B., Chandler L.J., and Lanier S.M. Expression analysis and subcellular distribution of the two G-protein regulators AGS3 and LGN indicate distinct functionality. Localization of LGN to the midbody during cytokinesis. J. Biol. Chem. 277 (2002) 15897-15903
5. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
6. Broderick P.A., Rahni D.N., and Zhou Y. Acute and subacute effects of risperidone and cocaine on accumbens dopamine and serotonin release using in vivo microvoltammetry on line with open-field behavior. Prog. Neuro-Psychopharmacol. Biol. Psych. 27 (2003) 1037-1054
7. Cameron H.A., and McKay R.D. Adult neurogenesis produces a large pool of new granule cells in the dentate gyrus. J. Complem. Neurol. 435 (2001) 406-417
8. 2+-induced stimulation of GFAP gene expression and regulates cortical astrogliogenesis. J. Neurosci. 28 (2008) 6703-6713
9. Celio M.R. Calbindin D-28k and parvalbumin in the rat nervous system. Neuroscience 35 (1990) 375-475
10. Chen S.J., Kao C.L., Chang Y.L., Yen C.J., Shui J.W., et al. Antidepressant administration modulates neural stem cell survival and serotoninergic differentiation through bcl-2. Curr. Neurovasc. Res. 4 (2007) 19-29
11. Clark D., Devoda I., Cordwell S., and Matsumoto I. A proteomics analysis of the anterior cingulated cortex gray matter in schizophrenia. Mol. Psychiatry 11 (2006) 459-470
12. Citrome L., Reist C., Palmer L., Montejano L., Lenhart G., Cuffel B., Harnett J., and Sanders K.N. Dose trends for second-generation antipsychotic treatment of schizophrenia and bipolar disorder. Schiz. Res. 108 (2009) 238-244
13. Cocco L., Faenza L., Fiume R., Billi A.M., Gilmour R.S., and Manzoli F.A. Phosphoinositide-specific phospholipase C (PI-PLC) (1 and nuclear lipid-dependent signalling. Biochim. Biophys. Acta (BBA)-Mol. Cell. Biol.-Lipids 1761 (2006) 509-521
14. Creed S.J., Bryce N., Naumanen P., Weinberger R., Lappalainen P., Stehn J., and Gunning P. Tropomyosin isoforms define distinct microfilament populations with different drug susceptibility. Eur. J. Cell Biol. 87 (2008) 709-720
15. Crews F.T., Nixon K., and Wilkie M.E. Exercise reverses ethanol inhibition of neural stem cell proliferation. Alcohol 33 (2004) 63-71
16. Czeh B., Michaelis T., Watanabe T., Frahm J., de Biurrun G., van Kampen M., Bartolomucci A., and Fuchs E. Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 12796-12801
17. Devi L.A., and Gomes I. G-protein mediated signaling pathway in neuritogenesis and neuronal survival. Neuropeptides 40 (2006) 435-436
18. Donohoe D.R., Weeks K., Aamodt E.J., and Dwyer D.S. Antipsychotic drugs alter neuronal development including ALM neuroblast migration and PLM axonal outgrowth in Caenorhabditis elegans. Int. J. Dev. Neurosci. 26 (2008) 371-380
19. Duman R.S. Depression: a case of neuronal life and death?. Biol. Psychiatry 56 (2004) 140-145
20. Fehér L.Z., Kálmán J., Puskás L.G., Gyülvészi G., Kitajka K., Penke B., Palotás M., Samarova E.I., Molnár J., Zvara A., Matin K., Bódi N., Hugyecz M., Pákáski M., Bjelik A., Juhász A., Bogáts G., Janka Z., and Palotás A. Impact of haloperidol and risperidone on gene expression profile in the rat cortex. Neurochem. Int. 47 (2005) 271-280
21. Ghezzi P. Regulation of protein function by glutathionylation. Free Radic. Res. 39 (2005) 573-580
22. Goebeler V., Ruhe D., Gerke V., and Rescher U. Annexin A8 displays unique phospholipid and F-actin binding properties. FEBS Lett. 580 (2006) 2430-2434
23. Green W., Patil P., Marsden C.A., Bennett G.W., and Wigmore P.M. Treatment with olanzapine increases cell proliferation in the subventricular zone and prefrontal cortex. Brain Res. 1070 (2006) 242-245
24. Grenklo S., Hillberg L., Zhao L.-S., Pinaev R.G., Clarence E., Schutt C.E., and Lindberg U. Tropomyosin assembly intermediates in the control of microfilament system turnover. Eur. J. Cell Biol. 87 (2008) 905-920
25. Harvey P., Green M.F., McGurk S.R., and Meltzer H.Y. Changes in cognitive functioning with risperidone and olanzapine treatment: a large scale, double-blind, randomized study. Psychopharmacology 169 (2003) 404-411
26. Hinova-Palova D.V., Edelstein L.R., Paloff A.M., Hristov S., Papantchev V.G., and Ovtscharoff W.A. Parvalbumin in the cat claustrum: ultrastructure, distribution and functional implications. Acta Histochem. 109 (2007) 61-77
27. Hinshelwood A., McGarvie G., and Ellis E. Characterisation of a novel mouse liver aldo-keto reductase AKR7A5. FEBS Lett. 523 (2002) 213-218
28. Horiuchi M., Far O.E., and Betz H. Ulip6, a novel unc-33 and dihydropyrimidinase related protein highly expressed in developing rat brain. FEBS Lett. 480 (2000) 283-286
29. Iwazaki T., McGregor I.S., and Matsumoto I. Protein expression profile in the striatum of rats with methamphetamine-induced behavioral sensitization. Proteomics 7 (2007) 1131-1139
30. Jarskog L.F., Miyamoto S., and Lieberman J.A. Schizophrenia: new pathological insights and therapies. Ann. Rev. Med. 58 (2007) 49-61
31. Johnston-Wilson N.L., Sims C.D., Hofmann J.P., Anderson L., Shore A.D., Torrey E.F., and Yolken R.H. Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder: the Stanley neuropathology consortium. Mol. Psychiatry 5 (2000) 142-149
32. Kashem, M.A., Etages, H.D., Kopitar-Jerala, N., McGregor, I.S., Matsumoto, I. Differential protein expression in the corpus callosum (body) of human alcoholic brain. J. Neurochem., in press.
33. Kashem M.A., Harper C., and Matsumoto I. Differential protein expression in the corpus callosum (Genu) of human alcoholics. Neurochem. Int. 53 (2008) 1-11
34. 2+ signaling in the regulation of alpha-amylase expression and germination of rice seed (Oryza sativa L.). Plant Cell Physiol. 41 (2000) 399-407
35. Kashem M.A., James G., Harper C., Wilce P., and Matsumoto I. Differential protein expression in the corpus callosum (splenium) of human alcoholics: a proteomics study. Neurochem. Int. 50 (2007) 450-459
36. Kasper S., and Resinger E. Cognitive effects and antipsychotic treatment. Psychoneuroendocrinology 28 (2003) 27-38
37. Klinzova A.J., Haselhorst U., Uranova N.A., Schenk H., and Isomin V.V. The effect of haloperidol on synaptic plasticity in rat medial prefrontal cortex. J. Hirnforsch. 30 (1989) 51-57
38. Konarzewska B., Wołczyński S., Szulc A., Galińska B., Popławska R., and Waszkiewicz N. Effect of risperidone and olanzapine on reproductive hormones, psychopathology and sexual functioning in male patients with schizophrenia. Psychoneuroendocrinology 34 (2009) 129-139
39. Kornhuber J., Schultz A., Wiltfang J., Meineke I., Gleiter C.H., Zöchling R., Boissl K.W., Leblhuber F., and Riederer P. Persistence of haloperidol in human brain tissue. Am. J. Psychiatry 156 (1999) 885-890
40. Kurosawa S., Hashimoto E., Ukai W., Toki S., Saito S., and Saito T. Olanzapine potentiates neuronal survival and neural stem cell differentiation: regulation of endoplasmic reticulum stress response proteins. J. Neural Transm. 114 (2007) 1121-1128
41. Lepore A.C., and Maragakis N.J. Targeted stem cell transplantation strategies in ALS. Neurochem. Int. 50 (2007) 966-975
42. Lidow M.S., Song Z.-M., Castner S.A., Allen P.B., Greengard P., and Goldman-Rakic P.S. Antipsychotic treatment induces alterations in dendrite- and spine-associated proteins in dopamine-rich areas of the primate cerebral cortex. Biol. Psychiatry 49 (2001) 1-12
43. Lin E.-Ju.D., Lee N.J., Slack K., Karl T., Duffy L., O'Brien E., Matsumoto I., Dedova I., Herzog H., and Sainsbury A. Distinct endocrine effects of chronic haloperidol or risperidone administration in male rats. Neuropharmacology 51 (2006) 1129-1136
44. Li X., Wong J., Tsai S.Y., Bert M.J., and O'Malley B.W. Progesterone and glucocorticoid receptors recruit distinct coactivator complexes and promote distinct patterns of local chromatin modification. Mol. Cell Biol. 23 (2003) 3763-3773
45. Lubec G., Nonaka M., Krapfenbauer K., Gratzer M., Cairns N., and Fountoulakis M. Expression of the dihydropyrimidinase related protein 2 (DRP-2) in Down syndrome and Alzheimer's disease brain is downregulated at the mRNA and dysregulated at the protein level. J. Neural Transm. Suppl. 57 (1999) 161-177
46. Madsen T., Treschow A., Bengzon J., Bolwig T.G., Lindvall O., and Tingstrom A. Increased neurogenesis in a model of electroconvulsive therapy. Biol. Psychiatry 47 (2000) 1043-1049
47. Mahadik S.P., and Mukherjee S. Free radical pathology and antioxidant defense in schizophrenia: a review. Schiz. Res. 19 (1996) 1-17
48. Malberg J., Eisch A.J., Nestler E.J., and Duman R.S. Chronic antidepressant treatment increases neurogenesis in adult hippocampus. J. Neurosci. 20 (2000) 9104-9110
49. Manev H., Uz T., Smalheiser N.R., and Manev R. Antidepressants alter cell proliferation in the adult brain in vivo and in neural cultures in vitro. Eur. J. Pharmacol. 411 (2001) 67-70
50. McKay R. Asymmetry, stem cells and the emergence of function. Clin. Neurosci. Res. 1 (2001) 183-186
51. Motamed K., and Sage E.H. SPARC inhibits endothelial cell adhesion but not proliferation through a tyrosine phosphorylation-dependent pathway. J. Cell. Biochem. 70 (1998) 543-545
52. Namslauer A., and Brzezinski P. Structural elements involved in electron-coupled proton transfer in cytochrome c oxidase. FEBS Lett. 567 (2004) 103-110
53. Natochin M., Lester B., Peterson Y.K., Bernard M.L., Lanier S.M., and Artemyev N.O. AGS3 inhibits GDP dissociation from galpha subunits of the Gi family and rhodopsin-dependent activation of transducin. J. Biol. Chem. 275 (2000) 40981-40985
54. Matsumoto I., Alexander-Kaufman K., Iwazaki T., Kashem M.A., and Matsuda- Matsumoto H. CNS proteome in drug abuse and dependence. Expert Rev. Proteomics 4 (2007) 539-552
55. Nilsson J., Söderberg O., Nilsson K., and Rosén A. Differentiation-associated redox-regulation in human B cell lines from stem cell/pro-B to plasma cell. Immunol. Lett. 94 (2004) 83-89
56. O'Brien E., Dedova I., Duffy L., Cordwell S., Karl T., and Matsumoto I. Effects of chronic risperidone treatment on the striatal protein profiles in rats. Brain Res. 1113 (2006) 24-32
57. Petreanu L., and Alvarez-Buylla A. Maturation and death of adult-born olfactory bulb granule neurons: role of olfaction. J. Neurosci. 22 (2002) 6106-6113
58. Poon H.F., Shepherd H.M., Reed T.T., Calabrese V., Stella A.-M., Pennisi G., Cai J., Pierce W.M., Klein J.B., and Butterfield D.A. Proteomics analysis provides insight into caloric restriction mediated oxidation and expression of brain proteins associated with age-related impaired cellular processes: mitochondrial dysfunction, glutamate dysregulation and impaired protein synthesis. Neurobiol. Aging 27 (2006) 1020-1034
59. Purdon S., Jones B.D., Stip E., Labelle A., Addington D., David S.R., Breier A., and Tollefson G.D. Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. Arch. Gen. Psychiatry 57 (2000) 249-258
60. Rastogi R.B., Singhal R.L., and Lapierre Y.D. Effects of short- and long-term neuroleptic treatment on brain serotonin synthesis and turnover: focus on the serotonin hypothesis of schizophrenia. Life Sci. 29 (1981) 735-741
61. Reddy R.D., Keshavan M., and Yao J.K. Reduced plasma antioxidants in first-episode patients with schizophrenia. Schiz. Res. 62 (2003) 205-212
62. Remington G. Alterations of dopamine and serotonin transmission in schizophrenia. Prog. Brain Res. 172 (2008) 117-140
63. Riaz S.S., Theofilopoulos S., Jauniaux E., Stern G.M., and Bradford H.F. The differentiation potential of human foetal neuronal progenitor cells in vitro. Dev. Brain Res. 153 (2004) 39-51
64. Shinohara H., Udagawa J., Morishita R., Ueda H., Otani H., Semba R., Kato K., and Asano T. Gi2 signaling enhances proliferation of neural progenitor cells in the developing brain. J. Biol. Chem. 279 (2004) 41141-41148
65. Shors T.J. Memory traces of trace memories: neurogenesis, synaptogenesis and awareness. Trends Neurosci. 27 (2004) 250-256
66. Shors T.J. From stem cells to grandmother cells: how neurogenesis relates to learning and memory. Cell Stem Cell 3 (2008) 253-258
67. Spitzer N.C., Gu X., and Olson E. Action potentials, calcium transients and the control of differentiation of excitable cells. Curr. Opin. Neurobiol. 4 (1994) 70-77
68. Sprague D.A., Loewen P.S., and Raymond C.B. Selection of atypical antipsychotics for the management of schizophrenia. Ann. Pharmacother. 38 (2004) 313-319
69. Storey J.D. A direct approach to false discovery rates. J. Res. Stat.: Stat. Method 64 (2002) 479-498
70. Takesono A., Cismowski M.J., Ribas C., Bernard M., Chung P., Hazard S., Duzic E., and Lanier S.M. Receptor-independent activators of heterotrimeric G-protein signaling pathways. J. Biol. Chem. 274 (1999) 33202-33205
71. Tateno M., Ukai W., Hashimoto E., Ikeda H., and Saito T. Implication of increased NRSF/REST binding activity in the mechanism of ethanol inhibition of neuronal differentiation. J. Neural Transm. 113 (2006) 283-293
72. Taymans J.-M., Kia H.K., and Langlois X. Activator of G protein signaling type 3 mRNA is widely distributed in the rat brain and is particularly abundant in the subventricular zone-olfactory bulb system of neural precursor cell proliferation, migration and differentiation. Neurosci. Lett. 391 (2006) 116-121
73. Thompson J.E., Hopkins M.T., Taylor C., and Wang T.W. Regulation of senescence by eukaryotic translation initiation factor 5A: implications for plant growth and development. Trends Plant Sci. 9 (2002) 174-179
74. Tome M.E., Fiser S.M., Payne C.M., and Gerner E.W. Excess putrescine accumulation inhibits the formation of modified eukaryotic initiation factor 5A (eIF-5A) and induces apoptosis. Biochem. J. 328 (2000) 847-854
75. Tsim T.Y., Wong E.Y.K., Leung M.S., and Wong C.-C. Expression of axon guidance molecules and their related genes during development and sexual differentiation of the olfactory bulb in rats. Neuroscience 123 (2004) 951-965
76. Ukai W., Ozawa H., Tateno N., Hashimoto E., and Saito T. Neurotoxic potential of haloperidol in comparison with risperidone: implication of Akt-mediated signal changes by haloperidol. J. Neural Transm. 111 (2004) 667-681
77. Wakade C.G., Mahadik S.P., Waller J.L., and Chiu F.C. Atypical neuroleptics stimulate neurogenesis in adult rat brain. J. Neurosci. Res. 69 (2002) 72-79
78. Weitzdoerfer R., Fountoulakis M., and Lubec G. Aberrant expression of dihydropyrimidinase related proteins-2, -3 and -4 in fetal Down syndrome brain. J. Neural Transm. Suppl. 61 (2001) 95-107
79. Westenbroek R.E., Hell J.W., Warner C., Dubel S.J., Snutch T.P., and Catterall W.A. Biochemical properties and subcellular distribution of an N-type calcium channel alpha 1 subunit. Neuron 6 (1992) 1099-1115
80. Yan Q., and Sage E.H. SPARC, a matrixcellular glyprotein with important biological functions. J. Histochem. Cytochem. 47 (1999) 1495-1505
81. Zhang X., Beaulieu J.-M., Sotnikova T.D., Gainetdinov R.R., and Caron M.G. Tryptophan hydroxylase-2 controls brain serotonin synthesis. Science 305 (2004) 217
82. Zhang X.Y., Tan Y.L., Cao L.Y., Wu G.Y., Xu O., Shen Y., and Zhou D.F. Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics. Schiz. Res. 81 (2006) 291-300
83. Zusso M., Debetto P., Guidolin D., Barbierato M., Manev H., and Giusti P. Fluoxetine-induced proliferation and differentiation of neural progenitor cells isolated from rat postnatal cerebellum. Biochem. Pharmacol. 76 (2008) 391-403